Remove 2028 Remove Communication Remove FDA
article thumbnail

Revolution Medicines partners Royalty Pharma on $2bn funding

Pharmaceutical Technology

The first tranche will be received by Revolution, following US Food and Drug Administration (FDA) approval of daraxonrasib to treat metastatic PDAC by January 2028. The debt facility portion consists of three tranches totalling up to $750m linked directly to daraxonrasib’s commercial milestones. Sign up for our daily news round-up!

article thumbnail

MSD’s Keytruda use in adenocarcinoma could be limited based on biomarker

Pharmaceutical Technology

In 2021, as part of the same Keynote-811 trial, the US Food and Drug Administration (FDA) granted accelerated approval to Keytruda for treating locally advanced unresectable or metastatic HER2-positive gastric or GEJ adenocarcinoma, in combination with trastuzumab and chemotherapy containing fluoropyrimidin and platinum.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen scores Otezla patent win in court to keep competition at bay

Pharmaceutical Technology

The district court had previously blocked Sandoz and Zydus from producing, selling, offering to sell, or importing generic versions of Otezla until February 2028. Since the lawsuit began, the FDA has approved Bristol Myers Squibb’s (BMS) Sotyktu (deucravacitinib), another small molecule for psoriasis treatment.

FDA 52
article thumbnail

Merck agrees to acquire Verona Pharma for $10bn

Pharmaceutical Technology

Find out more The transaction will enhance Merck’s cardio-pulmonary pipeline and portfolio with the addition of Ohtuvayre (ensifentrine), an FDA-approved treatment for chronic obstructive pulmonary disease (COPD) in adults. Credit: Merck & Co., Give your business an edge with our leading industry insights.

article thumbnail

How much is Addyi without insurance?

The Checkup by Singlecare

manufactures, was approved by the Food and Drug Administration ( FDA ) in August 2015 for hypoactive sexual desire disorder ( HSDD ) in pre-menopausal women. Addyi is currently only available as a brand-name drug , but a generic Addyi may be available after 2028. What is the generic for Addyi ? Is Addyi covered by insurance?

article thumbnail

State-Led Food Transparency: Texas and Louisiana Lead the Charge

The FDA Law Blog

On June 22, 2025, Texas Governor Greg Abbott signed into law SB 25 —nicknamed the “Make Texas Healthy Again” law—requiring, among other things, that any food or beverage containing one of 44 specified “ingredients” must carry a prominent warning label if FDA “requires the ingredient to be named on a food label.” What Made the List?

article thumbnail

Overview of the Internet of Medical Things (IoMT) 

Viseven

million in 2028, according to Statista. They need approval from healthcare authorities, such as the Food and Drug Administration (FDA). In the European Union, they must comply with the Medical Device Regulation to ensure traceability, while in the United States, the FDA oversees technology safety. million in 2025 to 67.49